Discern Health

News

W2O acquires health policy consulting firm Discern Health

W2O has bought US health economics and outcomes research company Discern Health, marking its sixth acquisition in less than a year.

R&D

pharmaphorum podcast Episode 224, Sigma Mostafa, KBI Biopharma

CDMOs: Their crucial role and how to select one, with Sigma ...

Sigma Mostafa, CSO at KBI BioPharma, discusses the role of CDMOs and the important factors companies should consider when selecting one.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Editor's Picks